Factor XIII B Rabbit Polyclonal Antibody
To Order Contact us: [email protected]
Factor XIII Rabbit Polyclonal Antibody |
|||
| E10G23332 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Rabbit Polyclonal Factor XIII Antibody |
|||
| TA590714 | Origene Technologies GmbH | 100 µg | Ask for price |
Rabbit Polyclonal antibody to Factor XIIIa (coagulation factor XIII, A1 polypeptide) |
|||
| TA308877 | Origene Technologies GmbH | 100 µl | Ask for price |
Rabbit polyclonal antibody to Factor XIIIa (coagulation factor XIII, A1 polypeptide) |
|||
| TA308878 | Origene Technologies GmbH | 100 µl | Ask for price |
Factor XIII B Polyclonal Antibody |
|||
| 40911 | SAB | 100ul | EUR 319 |
Factor XIII B Polyclonal Antibody |
|||
| 40911-100ul | SAB | 100ul | EUR 302.4 |
Factor XIII B Polyclonal Antibody |
|||
| 40911-50ul | SAB | 50ul | EUR 224.4 |
Factor XIII B Polyclonal Antibody |
|||
| ABP54193-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of Factor XIII B from Human. This Factor XIII B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human Factor XIII B at AA rangle: 30-110 |
|||
Factor XIII B Polyclonal Antibody |
|||
| ABP54193-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of Factor XIII B from Human. This Factor XIII B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human Factor XIII B at AA rangle: 30-110 |
|||
Factor XIII B Polyclonal Antibody |
|||
| ABP54193-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of Factor XIII B from Human. This Factor XIII B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human Factor XIII B at AA rangle: 30-110 |
|||
Factor XIII B Polyclonal Antibody |
|||
| ABP57388-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of Factor XIII B from Human. This Factor XIII B antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Factor XIII B |
|||
Factor XIII B Polyclonal Antibody |
|||
| ABP57388-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of Factor XIII B from Human. This Factor XIII B antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Factor XIII B |
|||
Factor XIII B Polyclonal Antibody |
|||
| ABP57388-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of Factor XIII B from Human. This Factor XIII B antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Factor XIII B |
|||
Factor XIII B Polyclonal Antibody |
|||
| BT-AP03125-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
|
Description: F13B encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. |
|||
Factor XIII B Polyclonal Antibody |
|||
| BT-AP03125-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
|
Description: F13B encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. |
|||
Factor XIII B Polyclonal Antibody |
|||
| BT-AP03125-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
|
Description: F13B encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. |
|||
Factor XIII B Polyclonal Antibody |
|||
| BT-AP03126-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
|
Description: F13B (coagulation factor XIII B chain) encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. |
|||
Factor XIII B Polyclonal Antibody |
|||
| BT-AP03126-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
|
Description: F13B (coagulation factor XIII B chain) encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. |
|||
Factor XIII B Polyclonal Antibody |
|||
| BT-AP03126-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
|
Description: F13B (coagulation factor XIII B chain) encodes coagulation factor XIII B subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon activation by the cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. |
|||
Factor XIII B Polyclonal Antibody |
|||
| JOT-AP03125-100ul | Jotbody | 100ul | EUR 220 |
|
Description: Human |
|||
Factor XIII B Polyclonal Antibody |
|||
| JOT-AP03125-50ul | Jotbody | 50ul | EUR 144 |
|
Description: Human |
|||
Factor XIII B Polyclonal Antibody |
|||
| JOT-AP03126-100ul | Jotbody | 100ul | EUR 220 |
|
Description: Human |
|||
Factor XIII B Polyclonal Antibody |
|||
| JOT-AP03126-50ul | Jotbody | 50ul | EUR 144 |
|
Description: Human |
|||
Factor XIII B Polyclonal Antibody |
|||
| E040911 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
Factor XIII B Polyclonal Antibody |
|||
| E20-75701 | EnoGene | 100ug | EUR 225 |
|
Description: Available in various conjugation types. |
|||
Factor XIII B Polyclonal Antibody |
|||
| E44H04692 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Factor XIII B Polyclonal Antibody |
|||
| E44H07143 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
Factor XIII B Polyclonal Antibody |
|||
| E20-71654 | EnoGene | 100ug | EUR 225 |
|
Description: Available in various conjugation types. |
|||
Factor XIII B Polyclonal Antibody |
|||
| MBS2549401-002mL | MyBiosource | 0.02mL | EUR 140 |
Factor XIII B Polyclonal Antibody |
|||
| MBS2549401-006mL | MyBiosource | 0.06mL | EUR 180 |
Factor XIII B Polyclonal Antibody |
|||
| MBS2549401-012mL | MyBiosource | 0.12mL | EUR 260 |
Factor XIII B Polyclonal Antibody |
|||
| MBS2549401-02mL | MyBiosource | 0.2mL | EUR 405 |
Factor XIII B Polyclonal Antibody |
|||
| MBS2538188-002mL | MyBiosource | 0.02mL | EUR 140 |
Factor XIII B Polyclonal Antibody |
|||
| MBS2538188-006mL | MyBiosource | 0.06mL | EUR 180 |
Factor XIII B Polyclonal Antibody |
|||
| MBS2538188-012mL | MyBiosource | 0.12mL | EUR 260 |
Factor XIII B Polyclonal Antibody |
|||
| MBS2538188-02mL | MyBiosource | 0.2mL | EUR 405 |
Factor XIII B Polyclonal Antibody |
|||
| MBS9246317-01mL | MyBiosource | 0.1mL | EUR 415 |
Factor XIII B Polyclonal Antibody |
|||
| MBS9246317-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
Factor XIII B Polyclonal Antibody |
|||
| MBS9243616-01mL | MyBiosource | 0.1mL | EUR 415 |
Factor XIII B Polyclonal Antibody |
|||
| MBS9243616-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8526682-01mg | MyBiosource | 0.1mg | EUR 305 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8526682-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8526682-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8526682-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8526682-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8522635-01mg | MyBiosource | 0.1mg | EUR 305 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8522635-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8522635-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8522635-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
Factor XIII B Polyclonal Antibody |
|||
| MBS8522635-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
Factor XIII B Polyclonal Antibody |
|||
| MBS9406236-005mL | MyBiosource | 0.05mL | EUR 245 |
Factor XIII B Polyclonal Antibody |
|||
| MBS9406236-01mL | MyBiosource | 0.1mL | EUR 305 |
Factor XIII B Polyclonal Antibody |
|||
| MBS9406236-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
Factor XIII B Polyclonal Antibody |
|||
| UB-GEN-3782 | UpingBio | 100 ul | EUR 200 |
Factor XIII B Polyclonal Antibody |
|||
| UB-GEN-4262 | UpingBio | 100 ul | EUR 200 |
Factor XIII B Polyclonal Conjugated Antibody |
|||
| C40911 | SAB | 100ul | EUR 476.4 |
Factor XIII B Polyclonal Conjugated Antibody |
|||
| MBS9449793-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
Factor XIII B Polyclonal Conjugated Antibody |
|||
| MBS9449793-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
Factor XIII B Polyclonal Conjugated Antibody |
|||
| MBS9449793-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
Factor XIII B Polyclonal Conjugated Antibody |
|||
| MBS9449793-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
Factor XIII B Polyclonal Conjugated Antibody |
|||
| MBS9449793-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
Factor XIII polyclonal antibody |
|||
| BZ16156 | Bioworld Biotech | 50ul | EUR 358 |
|
Description: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3. |
|||